638 related articles for article (PubMed ID: 7021432)
1. Digitalis therapy in renal failure with special regard to digitoxin.
Vöhringer HF; Rietbrock N
Int J Clin Pharmacol Ther Toxicol; 1981 Apr; 19(4):175-84. PubMed ID: 7021432
[TBL] [Abstract][Full Text] [Related]
2. Current status of cardiac glycoside drug interactions.
Hooymans PM; Merkus FW
Clin Pharm; 1985; 4(4):404-13. PubMed ID: 2412751
[TBL] [Abstract][Full Text] [Related]
3. Digitalis pharmacokinetics and therapy with respect to impaired renal function.
Kramer P
Klin Wochenschr; 1977 Jan; 55(1):1-11. PubMed ID: 319291
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of digoxin absorption but not of digitoxin during cytostatic drug therapy.
Kuhlmann J
Arzneimittelforschung; 1982; 32(6):698-704. PubMed ID: 6889430
[TBL] [Abstract][Full Text] [Related]
5. Digitalis pharmacokinetics and metabolism.
Marcus FI
Am J Med; 1975 Apr; 58(4):452-9. PubMed ID: 1092160
[TBL] [Abstract][Full Text] [Related]
6. [Proceedings: Clinical value of serum digoxin and digitoxin determination in renal insufficiency].
Klauser-Reucker C; Ferrini B; Klauser H; Moccetti T
Schweiz Med Wochenschr; 1975 Dec; 105(51):1784-6. PubMed ID: 1215979
[TBL] [Abstract][Full Text] [Related]
7. Digitalis in chronic renal insufficiency.
Rambausek M; Ritz E
Blood Purif; 1985; 3(1-3):4-14. PubMed ID: 3006726
[TBL] [Abstract][Full Text] [Related]
8. [Recent advances in digitalis therapy].
Kolenda KD; Grille W; Kokenge F
Z Arztl Fortbild (Jena); 1982 Nov; 76(21):923-30. PubMed ID: 7170801
[No Abstract] [Full Text] [Related]
9. [Prospective examinations of digitalis poisoning].
Storstein L
Fortschr Med; 1981 Aug; 99(31-32):1247-54. PubMed ID: 7274939
[TBL] [Abstract][Full Text] [Related]
10. [Clinical study on digoxin tablets with high bioavailability (author's transl)].
Flasch CI; Heinz N
Arzneimittelforschung; 1979; 29(6):961-4. PubMed ID: 582792
[TBL] [Abstract][Full Text] [Related]
11. Tritiated digoxin: studies in renal disease in human subjects.
Doherty JE; Bissett JK; Kane JJ; de Soyza N; Murphy ML; Flanigan WJ; Dalrymple GV
Int J Clin Pharmacol Biopharm; 1975 Jul; 12(1-2):89-95. PubMed ID: 1100542
[TBL] [Abstract][Full Text] [Related]
12. The quinidine-digoxin interaction in patients with impaired renal function.
Fichtl B; Doering W; Seidel H
Int J Clin Pharmacol Ther Toxicol; 1983 May; 21(5):229-33. PubMed ID: 6862727
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetic aspects of digoxin in patients with terminal renal failure. IV. Clinical implications of own observations with a recent review of literature.
van der Vijgh WJ; Oe PL
Int J Clin Pharmacol Biopharm; 1978 Nov; 16(11):540-6. PubMed ID: 730421
[TBL] [Abstract][Full Text] [Related]
14. [Trial for digitalis withdrawal in hemodialysis patients].
Keller F; Schwarz A; Offermann G; Molzahn M; Distler A; Kreutz G; Weinmann J; von Leitner ER; Vöhringer HF
Dtsch Med Wochenschr; 1984 Feb; 109(8):290-4. PubMed ID: 6230217
[TBL] [Abstract][Full Text] [Related]
15. Factors of importance for valid digitalis assays particularly for the determination of digoxin in plasma and urine.
Molin L
Acta Pharmacol Toxicol (Copenh); 1986; 59 Suppl 4():1-62. PubMed ID: 3739734
[TBL] [Abstract][Full Text] [Related]
16. [Do we use digitalis properly in the management of elderly patients suffering from the signs of chronic heart failure?].
Erdei F; Vendrey R; Dani G; Kovács E; Márk L; Katona A
Orv Hetil; 2006 Oct; 147(41):1993-6. PubMed ID: 17120690
[TBL] [Abstract][Full Text] [Related]
17. Differential effect of chronic renal failure on the pharmacokinetics of lidocaine in patients receiving and not receiving hemodialysis.
De Martin S; Orlando R; Bertoli M; Pegoraro P; Palatini P
Clin Pharmacol Ther; 2006 Dec; 80(6):597-606. PubMed ID: 17178261
[TBL] [Abstract][Full Text] [Related]
18. [Epidemiology of digitalis medication. Results of the Munich blood-pressure study].
Koenig W; Keil U; Stieber J; Döring A; Pöppl SJ; Mraz W
Dtsch Med Wochenschr; 1984 Mar; 109(11):412-8. PubMed ID: 6697899
[TBL] [Abstract][Full Text] [Related]
19. Digoxin pharmacokinetics and dosage requirements in pediatric patients.
Bendayan R; McKenzie MW
Clin Pharm; 1983; 2(3):224-35. PubMed ID: 6349908
[TBL] [Abstract][Full Text] [Related]
20. [Pharmacokinetics of cardiac glycosides and clinical consequences].
Rietbrock N; Kuhlmann J; Vöhringer HF
Fortschr Med; 1977 Apr; 95(14):909-15, 951-4. PubMed ID: 856698
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
